REFERENCES
- Hanefeld M, Fischer S, Julius U et al. Risk factors for myocardial infarction and death in newly detected NIDDM : the diabetes intervention study, 11-year follow-up. Diabetologia 1996; 39: 1577–1583.
- The DECODE Study Group. Glucose tolerance and cardiovascular mortality. Comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001; 161: 310–314.
- Haffner SM. The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease. Endocrine Rev 1998; 19: 583–592.
- Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996; 20: 707–727.
- Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000; 87: 840–844.
- Ceriello A, Lizzio S, Bortolotti Net al. Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care 1998; 21: 1529–1533.
- Kawano H, Motoyama T, Hirashima 0 et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 1999; 34: 146–154.
- Ceriello A, Quagliaro L, Catone B et al. Role of hyperglycemia in nitrotyrosine postprandial generation. Diabetes Care 2002; 25: 1439–1443.
- Ceriello A, Russo PD, Amstad P. Cerutti P. High glucose induces antioxidant enzymes in human endothelial cells in culture: evidence linking hyperglycemia and oxidative stress. Diabetes 1996; 45: 471–477.
- Consentino F, Hishikawa K, Katusic ZS, Liischer TF. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 1997; 96: 25–28.
- Nishikawa T, Edelstein D, Du XL et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000; 404: 787–790.
- Inoguchi T, Li P, Umeda F et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000; 49: 1939–1945.
- Guzik TJ, Mussa S, Gastaldi D et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus. Role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 2002; 105: 1656–1662.
- Itoh Y, Ma FH, Hoshi H et al. Determination and bioimaging method for nitric oxide in biological specimens by diaminofluorescein fluorometry. Anal Biochem 2000; 287; 203–209.
- Myhre 0, Andersen JM, Aarnes H, Fonnum F. Evaluation of the probes 2',7'-dichlorofluorescein diacetate, luminal, and lucigenin as indicators of reactive species formation. Biochem Pharmacol 2003; 65: 1575–1582.
- Virag L, Szabo E, Gergely P. Szabo C. Peroxynitrate-induced cytotoxicity: mechanism and opportunities for intervention. Toxicol Lett 2003; 140/141: 113–124.
- Chung SS, Ho EC, Lam KS, Chung SK. Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol 2003; 14: S233–S236.
- Kuboki K, Jiang ZY, Takahara Net al. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 2000; 101: 676–681.
- Kashiwagi A, Shinozuka K, Nishio Yet al. Endothelium-specific activation of NAD(P)H oxidase in aortas of exogenously hyperinsulinemic rats. Am J Physiol 1999; 277: E976–E983.
- Miles AM, Bohle S, Glassbrenner PA, Hansert B, Wink DA, Grisham MB. Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J Biol Chem 1996; 271: 40–47.
- Berka V, Chen PF, Tsau AL. Spatial relationship between L-arginine and heme binding sites of endothelial nitric-oxide synthase. J Biol Chem 1996; 271: 33293–33000.
- Shinozaki K, Nishio Y, Okamura T et al. Oral administration of tetrahydrobiopterin prevents endothelial dysfunction and vascular oxidative stress in the aortas of insulin-resistant rats. Circ Res 2000; 87: 566–573.